Moderna | search
Click here to view Moderna news from 60+ newspapers.
Bookmark or Share- Moderna – 2024 Shareholder Letter from CEO Stéphane BancelModerna has added its 2024 Shareholder Letter from CEO Stéphane Bancel to its website. As we reflect on 2024, it is clear that the past year brought formidable challenges for Moderna along with significant advances, particularly for our development pipeline.
- Company Culture - ModernaJoin Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.
- Investor Relations Overview - ModernaOverview of Moderna news, events & presentations, latest quarterly results, and Moderna's pipeline development programs.
- Pioneering mRNA technology - ModernaModerna's mission is to deliver the greatest possible impact to people through mRNA medicines.
- Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical TrialsModerna is advancing five vaccine candidates against viruses that cause latent infections, all of which are in clinical trials. When latent, a virus is present in the body but exists in a resting state, typically without causing any noticeable symptoms.
More
